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Introduction: Optimal feeding of critically ill patients in the ICU is controversial. Existing guidelines rest on rather
weak evidence. Whole body protein kinetics may be an attractive technique for assessing optimal protein intake. In
this study, critically ill patients were investigated during hypocaloric and normocaloric IV nutrition.
Methods: Neurosurgical patients on mechanical ventilation (n = 16) were studied during a 48-hour period. In
random order 50% and 100% of measured energy expenditure was given as IV nutrition during 24 hours,
corresponding to hypocaloric and normocaloric nutrition, respectively. At the end of each period, whole body
protein turnover was measured using d5-phenylalanine and 13C-leucine tracers.
Results: The phenylalanine tracer indicated that whole-body protein synthesis was lower during hypocaloric
feeding, while whole-body protein degradation and amino acid oxidation were unaltered, which resulted in a more
negative protein balance, namely −1.9 ± 2.1 versus −0.7 ± 1.3 mg phenylalanine/kg/h (P = 0.014). The leucine tracer
indicated that whole body protein synthesis and degradation and amino acid oxidation were unaltered, but the
protein balance was negative during hypocaloric feeding, namely −0.3 ± 0.5 versus 0.6 ± 0.5 mg leucine/kg/h
(P < 0.001).
Conclusion: In the patient group studied, hypocaloric feeding was associated with a more negative protein
balance, but the amino acid oxidation was not different. The protein kinetics measurements and the study’s
investigational protocol were useful for assessing the efficacy of nutrition support on protein metabolism in
critically ill patients.
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Feeding critically ill patients in the ICU is a controversial
subject in many respects. Timing of feeding, caloric con-
tent, and protein content are all issues, and here,
existing guidelines are based upon a low level of scien-
tific evidence [1-3]. Why? Published studies are old, and
often used obsolete techniques to evaluate the effects
from feeding [4]. While physiology is unchanged, treat-
ment (intensive care medicine) has changed, and this
limits the validity of studies from the last millennium.
Nitrogen balance constitutes the classic measurement
of protein intake effects. Limitations of the classic nitro-
gen balance technique are particularly pronounced in
intensive care although most limitations are general.* Correspondence: jan.wernerman@karolinska.se
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reproduction in any medium, provided the orWhile control over intake and output may be sufficient,
the steady-state criterion and adaption-to-intake criter-
ion (both critical for interpretation of data) are rarely
fulfilled. Meticulously performed nitrogen balance stud-
ies, however, form the foundation for current recom-
mendations [5,6]. Reports from body composition
studies are also part of the documentation behind
current recommendations. Techniques based on imped-
ance measurements are not reliable in critically ill pa-
tients (associated with rapid changes in body fluids).
Neutrone activation is a very attractive technique to as-
sess lean body mass [7] but low availability - and need
for patient transfer for assessment - limit its usefulness.
So far, no randomized prospective studies of protein in-
take in ICUs are available.
Whole body, protein kinetics measurements that use
isotopically labeled amino acid should be the techniqued. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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relation to protein intake. Protein synthesis and degrad-
ation can be assessed separately, and amino acid oxidation
and whole-body protein balance can be calculated. The
period during which a steady state is needed is relatively
short, and measures may be repeated. Despite these obvi-
ous benefits - at least in theory - only a few studies of crit-
ically ill patients are available [8-10]. There are relatively
more studies in burn patients [11,12], but the validity of
these studies for trauma and sepsis patients in general
ICUs is limited.
In this pilot study, we included a homogenous patient
group in a neurosurgical ICU. To optimize study condi-
tions, we limited inclusions to sedated, mechanically venti-
lated adult patients, who received only parenteral nutrition.
This selection, of course, limits the generalizability of re-
sults. Our main objective was to compare hypocaloric and
normocaloric feeding in terms of whole-body protein
kinetics.
Materials and methods
Patients admitted to the neurosurgical ICU at Karolinska
Solna were studied in the 2009 to 2011 period. Inclusion
criteria were (i) a diagnosis of traumatic brain injury or
intracranial bleeding, (ii) sedated and on mechanical
ventilation, and (iii) receiving parenteral nutrition. Ex-
clusion criteria were (i) age <18 years, and (ii) absence of
informed consent. The Ethics Committee of Karolinska
Institutet approved the protocol and the patients' rela-
tives gave informed consent after being informed ver-
bally and in writing about the investigational procedure
and possible risks.PN 50% of EE P
Day 1 D
IC IC
PN 100% of EE P
Day 1 D
IC IC
Primed isotop IV infusion
0 60
Figure 1 A schematic illustration of the study protocol. IC, indirect calo
IV, intravenous.The protocol included a 48-hour study period, starting
with an energy expenditure measurement by indirect
calorimetry during feeding (Deltatrac Metabolic Moni-
tor, Datex-Ohmeda, Helsinki, Finland). Thereafter, pa-
tients were randomized to one of two alternatives,
namely, to receive (i) 50% of the measured energy ex-
penditure during 24 hours before receiving 100% during
the consecutive 24 hours, or (ii) 100% of the measured
energy expenditure during 24 hours followed by 50% of
the measured energy expenditure during the next 24
hours. This protocol enabled patients to be their own
controls, provided the two consecutive days were com-
parable (Figure 1).
Nutrition was delivered as an all-in-one formulation:
Nutriflex Lipid Special (B Braun AG, Melsungen, Germany)
contains a protein-to-energy ratio of 0.049 g/kcal. The
intravenous (IV) nutrition infusion rate was set to give the
amount of calories measured as energy expenditure by the
indirect calorimetry. In cases when propofol was used for
sedation, the IV nutrition infusion rate was adjusted ac-
cordingly. So, in practice this further lowered the adminis-
tered protein-per-kg for most patients.
The whole-body protein turnover measurements were
made using isotopically labeled leucine and phenylalan-
ine in parallel. There were two study periods for each
patient, at the end of each 24-hour period, with one of
the two nutritional regimens.
On each occasion the patients received a primed con-
tinuous infusion of the labeled amino acids (Figure 1).
The prime consisted of ring-2H5-phenylalanine (0.5 mg/kg),
ring-2H4-tyrosine (0.15 mg/kg), 3,3-
2H2-tyrosine (0.3 mg/kg),
1-13C-leucine (0.9 mg/kg) and 13C-sodium-bicarbonateN 100% of EE
ay 2
IC





rimetry; EE, energy expenditure; PN, parenteral nutrition;
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alanine (0.5 mg/kg/h), 3,3-2H2-tyrosine (0.3 mg/kg/h)
and 1-13C-leucine (1.0 mg/kg/h) followed the prime.
All isotopes were obtained from Cambridge Isotopes
Inc. (Cambridge, MA, USA). The hospital pharmacy pre-
pared and tested sterile solutions for sterility and
pyrogenity. Labeled amino acids were administered
intravenously for 150 minutes before the sampling to
obtain an isotopic steady state before the sampling
period, which involved samples taken on 4 occasions
during the last 30 minutes of the infusion. Blood sam-
ples were taken from an arterial line. Plasma was
obtained and frozen at −80°C until analysis. Breath sam-
ples for 13CO2 measurements were taken from the
DeltaTrac Metabolic Monitor during the 30-minute
sampling periods. A Douglas bag was used, and the sam-
ples were transferred to vacutainers.
For analysis of the labeled amino acids, plasma was
deproteinized using sulfosalisylic acid. The amino acids
were cleaned using ion-exchange chromatography and dried
using rotary evaporation. The amino acids were derivatized
using N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide
(MTBSTFA). The amino acids were analyzed with an
Agilent N5973 gas chromatography and mass spectrometer
(GCMS; Agilent, Kista, Sweden) for m/z 336 and 341 for
phenylalanine, 302 and 303 for leucine, and 466, 468, and
470 for tyrosine.
Keto-isocaproic acid (KIC) enrichment in plasma was
analyzed by deproteinizing the plasma with ethanol and
drying the sample by rotary evaporation. KIC was then
derivatized with o-phenylenediamine - extracted in etha-
nol and dried again. The dried KIC is derivatized using
MTBSTFA and m/z of 259 and 260; it is analyzed with
GCMS. Amino acid concentrations in plasma were analyzed
by high pressure liquid chromatography (HPLC) using
on-column derivatization with ortho-phtaldialdehyde/3-
mercaptopropionic acid (OPA/3-MPA) as described earlier
[13]. Breath samples were analyzed for 13CO2 using a
BreathMat (Thermo Finnegan, Bremen, Germany).
Whole-body rate of appearances (Ra) for phenylalan-
ine and leucine were calculated:
Ra ¼ I= Ei=EAð Þ−1ð Þ;
in which I is the infusion rate of the tracer and Ei and
EA are the enrichments in the infusate and plasma
respectively. Plasma KIC enrichments were used for
leucine Ra calculation, and Ra plasma enrichments of
2H5-pheylalanine and
2H2-tyrosine were used for phenyl-
alanine and tyrosine, respectively. The endogenous rate
of appearance (endoRa) was calculated by subtracting
the amino acid infusions in the parenteral nutrition from
the Ra. Both amino acids are essential, and therefore theendoRa represents the whole-body protein breakdown
rate.
Because these measurements were done in a steady-
state situation, the Ra is equal to the rate of disappear-
ance (Rd). Whole body protein synthesis was calculated
by subtracting the oxidation rates for phenylalanine and
leucine from the Rd. Oxidation rates for leucine (Ox)
were estimated by the appearance of 13CO2 in the breath
and for phenylalanine by the flux to tyrosine (QPT). The
plasma KIC enrichments were used for the leucine cal-
culations because they better represent the intracellular
events [14]:
QPT ¼ RaTyr  EATyr=EAPhe
  RaPhe= IPhe þ RaPheð Þ
Leu Ox ¼ 0:8 VCO213CO2breathð Þ=EKIC
in which EATyr and EAPhe are the plasma enrichments of
2H4−tyrosine and
2H5-phenylalanine, IPhe is the infusion
rate of the phenylalanine tracer, VCO2 is the CO2 pro-
duction rate as measured by the DeltaTrac Metabolic
Monitor, 13CO2 is the enrichment in the breath samples
and EKIC is the enrichment of
13C-KIC in the plasma.
The factor 0.8 is to correct for the recovery of 13CO2
during the study period [15].
Whole-body protein synthesis rates were estimated by
subtracting the Ox from the Rd. Whole-body protein
balance was calculated by subtracting protein breakdown
(Ra phenylalanine or leucine) from this protein synthesis
rate.
Student’s t-test for paired samples was used for com-
paring the measurements in the hypocaloric and
normocaloric states. The Kolmogorov-Smirnov test was
used to test for normal distribution of the data. When
applicable (as indicated in the text), Wilcoxon’s rank test
was applied. A P-value <0.05 in a two-sided test was
considered statistically significant. STATISTICA soft-
ware (Statsoft, Uppsala, Sweden) was used for calcula-
tions. The sample size of 16 subjects was chosen to
enable us to combine the two randomized groups into
one by only applying a simple non-parametric sign test
(8 subjects in each group). In the literature the coeffi-
cient of variation for whole-body leucine kinetics in
healthy subjects is reported to 3 to 4% [16].
Results
Patients (n = 16) with traumatic brain injury or intracra-
nial bleeding were studied. They were sedated, and were
on mechanical ventilation and parenteral nutrition.
Seventeen patients were recruited into the study, but
one patient had to be excluded due to protocol violation
in terms of non-adhesion to the nutritional protocol.
The mean (± SD) age of the patients was 49.5 ± 10.4
years. The male/female gender distribution was 11/5
(see Table 1 for other patient characteristics). After
















79 TBI 3 17 5 Y 100/50 24.9 18.8 0.9
95 SDH 12 4 9 N 50/100 23.5 23.5 1.1
86 SDH 12 4 12 Y 100/50 25.8 24.6 1.2
76 SDH 3 8 9 Y 50/100 22.4 18.4 0.9
85 TBI 6 3 10 Y 100/50 27.0 25.9 1.3
77 ICH 6 10 6 Y 50/100 23.0 19.1 0.9
61 SAH 11 17 7 Y 100/50 31.3 20.3 1.2
78 TBI 6 5 9 Y 50/100 24.1 24.1 1.2
90 SAH 5 5 9 N 100/50 20.6 17.0 0.8
64 SDH 5 5 10 Y 50/100 25.8 16.4 0.8
65 EDH 4 4 9 Y 100/50 26.4 26.4 1.3
87 SDH 3 3 3 Y 50/100 19.9 19.9 1.0
89 SDH 4 1 7 Y 50/100 28.8 28.8 1.4
95 TBI 3 5 9 Y 100/50 27.1 26.5 1.3
100 SDH 5 11 7 Y 50/100 25.7 22.5 1.1
85 SDH 8 1 9 Y 100/50 18.9 15.5 0.8
Full patient sample (n = 16), mean values (SD)
82.0 NA 6.0 6.4 8.1 NA NA 24.7 21.7 1.1
(11.5) NA (3.1) (5.0) (2.2) NA NA (3.3) (4.1) (0.2)
aPercent measured energy expenditure (EE) during 24 hours/percent measured EE during the next consecutive 24 hours. TBI, traumatic brain injury; SDH, subdural
hemorrhage; ICH, ischemic brain injury; SAH, subarachnoid hemorrhage; EDH, epidural hemorrhage; GCS, Glasgow coma scale; SOFA, sequential organ failure
assessment score; EE, energy expenditure; TPN, total parenteral nutrition; Y, yes; N, no; NA, not applicable.
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etry, patients were randomized into the two groups to
be studied for 48 hours, namely, hypocaloric before
normocaloric, or normocaloric before hypocaloric. Pa-
tients were studied on day 6 (range 1 to 17 days) of the
ICU stay; when given normocaloric feeding the total par-
enteral nutrition (TPN) contained 21.7 ± 4.1 kcal/kg/24
h and 1.07 ± 0.15 g protein/kg/24 h (Table 1). For indi-
vidual patients, part of the energy supply was contained
in the sedation given. The two patient subgroups were
compared statistically for all variables shown below; no
significant differences were observed. In Figures 1 and 2
the two subgroups are indicated.
Indirect calorimetry was repeated three times for each
patient; (i) before randomization, (ii) after 24 hours of
being given parenteral nutrition (PN) of 100% of mea-
sured EE, and (iii) after 24 hours of being given PN oft
50% of measured EN (Figure 1). Pre-study EE was 24.7 ±
3.3 kcal/kg/24 h, which was not different from the en-
ergy expenditure obtained after being given 24 hours of
PN at 100% of measured EE, 24.5 ± 2.3 kcal/kg/24 h,
while the measured energy expenditure after being given
24 hours of 50% of measured EE was 4% lower at 23.4 ±
2.4 kcal/kg/24 h (P = 0.049). For the respiratoryquotient, the pre-study value was not different from the
value obtained after being given 24 hours of PN at 100%
of measured EE, 0.80 ± 0.10 and 0.82 ± 0.10, respect-
ively. On the other hand, after being given 24 hours of
PN of 50% of measured EE the respiratory quotient was
lower at 0.76 ± 0.01 (P = 0.005) compared to the value
obtained after 24 hours of 100% of measured EE.
Because the amount of protein given was different due
to the use of an all-in-one formulation, the free amino
acids were measured in plasma. The total sum of free
amino acids in plasma did not change significantly, with
2.8 ± 0.5 mmol/L versus 2.9 ± 0.4 mmol/L (P = 0.085)
for PN of 50% and 100% of measured EE, respectively.
Insulin administration at the time of protein turnover
measurements was recorded retrospectively. Eight pa-
tients were not given insulin; the remaining eight pa-
tients were given 5.8 ± 5.0 (median 4.0) U/h when given
100% of EE, and 3.2 ± 2.1 (median 3.5) U/h when 50%
of EE was given. When all 16 patients are combined the
corresponding values are 2.9 ± 3.8 (median 1.0) U/h and
1.6 ± 2.7 (median 0.0) U/h (P >0.05 (Wilcoxon test) in
both calculations).
Whole-body protein turnover was measured during
the last 30 minutes of 24 hours of PN, corresponding to
Figure 2 Whole body protein kinetics, calculated using a phenylalanine tracer, in critically ill mechanically ventilated neurosurgical
patients (n = 16) who received normocaloric and hypocaloric intravenous nutrition in random order during two consecutive days.
Patients were randomized to receive normocaloric before hypocaloric (filled symbols), or hypocaloric before normocaloric (open symbols)
nutrition. (A) Whole-body protein synthesis; (B) whole-body protein degradation; (C) phenylalanine oxidation; (D) whole-body protein balance.
P-values are for paired comparisons. Phe, phenylalanine. Red lines indicate mean values.
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ments with a phenylalanine tracer). Whole-body pro-
tein synthesis was 12% lower when 50% of EE was
given, 11.7 ± 3.0 versus 13.3 ± 2.2 mg phenylalanine/
kg/h (P = 0.025), whereas whole-body protein degrad-
ation was also unaltered at 13.6 ± 3.5 versus 14.0 ± 2.6
mg phenylalanine/kg/h (P = 0.56). Whole-body protein
oxidation was unaltered at 3.0 ± 2.1 versus 2.9 ± 1.4 mg
phenylalanine/kg/h (P = 0.85), but the difference in the
whole-body synthesis rate resulted in a 60% difference in
whole-body protein balance, with −1.9 ± 2.1 versus −0.7 ±
1.3 mg phenylalanine/kg/h (P = 0.001, Wilcoxon test).
Figure 3 illustrates the results with a leucine tracer.
The difference in whole-body protein balance remained
at −0.3 ± 0.5 compared to 0.6 ± 0.5 mg leucine/kg/h
(P <0.001) for PN of 50% and 100% of measured EE,
respectively, and simultaneously the whole-body pro-
tein oxidation was unaltered at 1.3 ± 0.5 versus 1.4 ±
0.5 mg leucine/kg/h (P = 0.19). For whole-body syn-
thesis and degradation the results were different;
whole-body protein synthesis was unaltered at 20.7 ±
4.1 versus 20.5 ± 2.8 mg leucine/kg/h (P = 0.69), andso was whole-body protein degradation at 21.0 ± 4.4
versus 19.9 ± 2.8 mg leucine/kg/h (P = 0.11).
Discussion
Whole-body protein kinetics were studied in patients in
the neurosurgical ICU, who were sedated and on mech-
anical ventilation, and were receiving hypocaloric and
normocaloric feeding by standard PN. The major finding
was that full feeding resulted in a less negative or posi-
tive whole-body protein balance, and that simultaneously
the amino acid oxidation was not different.
The study protocol using two consecutive days, during
which patients received two different treatments, is an
attractive option in studies of heterogenous patient
groups, such as critically ill patients [17-19]. Due to
randomization of the time order of treatments and com-
parability of patients' characteristics on the two days, we
can assume that conditions outside the intervention
were reasonably similar and therefore, that this enabled
a fair comparison. The study of neurosurgical patients
on mechanical ventilation also made indirect calorimetry
applicable, as the oxygen fraction was low in all patients.
Figure 3 Whole body protein kinetics, calculated using a leucine tracer, in critically ill mechanically ventilated neurosurgical patients
(n = 16) who received normocaloric and hypocaloric intravenous nutrition in random order during two consecutive days. Patients were
randomized to receive normocaloric before hypocaloric (filled symbols), or hypocaloric before normocaloric (open symbols) nutrition. (A) Whole-
body protein synthesis; (B) whole-body protein degradation; (C) leucine oxidation; and (D) whole-body protein balance. P-values are for paired
comparisons. Leu, leucine. Red lines indicate mean values.
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ment conditions by means of (i) a homogenous group of
patients, (ii) high probability of two comparable con-
secutive 24-hour periods, and (iii) full control over nutri-
tion by the parenteral route. Naturally, these inclusion
criteria limit the external validity of the study, but under
these conditions, the nutrition made a difference for
whole-body protein kinetics, which was not just a
combusted caloric intake, as reflected by the amino acid
oxidation. It is, however, beyond the scope of the study
to speculate over the possible clinical relevance of this
finding. Still, it is reasonable to conclude that the results
demonstrate the usefulness of the applied technique and
protocol, which suggests its use in studies in the future.
Measured EE determined the caloric supply, whereas
the composition of the specific all-in-one formulation
used determined the protein supply. The protein sup-
ply level was below the recommendation given in the
European Society of Clinical Nutrition and Metabolism
(ESPEN) guidelines [1]. An interesting observation is
that the amino acid oxidation level was not different be-
tween the two levels of protein supply, which suggests that
a protein supply of 1.07 + 0.15 g protein/kg/24 h waseffectively utilized. Future studies will address the question
of the optimal protein supply level [20].
In an earlier study including singular measurements in
a small group of general ICU patients and of volunteers,
we also used phenylalanine and leucine tracers in paral-
lel [21]. The rationale for using parallel tracers was that
existing literature on whole-body protein kinetics evalu-
ated by these two tracers, tends to show a uniform result
for the protein balance level, but the contributions from
changes in whole-body protein synthesis and breakdown
may be related to the amino acid tracer used [22]. Our
pilot experience reproduced that finding. So, in the
present study we continued to use parallel tracers and
again found this difference. The phenylalanine tracer in-
dicated a less negative whole-body protein balance when
receiving 100% of EE related to a higher rate of whole-
body protein synthesis, while the leucine tracer gave a
similar result for whole-body protein balance, related to
a tendency (not statistically significant) towards a lower
rate of protein degradation.
The mechanism(s) behind the varying results obtained
with the phenylalanine and leucine tracers is/are obscure.
A possible explanation is the variation in representation in
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tracers. Phenylalanine probably better represents the liver,
while leucine (or more correctly α-keto-iso-caproate,
which is used for the calculations) better represents skel-
etal muscle.
The generalizability of our data is limited due to: (i)
the study population having narrow inclusion criteria,
(ii) patients being on PN only, and (iii) the low nitrogen-
to-calorie ratio in the commercially available formulation
that was used. So, the difference between hypocaloric
and normocaloric supply may be attributed to the ad-
ministered caloric levels or to the protein (amino acid)
levels, or a combination of the two. Clearly, further stud-
ies are needed to settle this point. The time course dur-
ing the ICU stay, and the possibility of an adaptation
period after changes in protein intake, are other issues
that need to be addressed in the future.
The limitation related to the use of PN only constitutes
a technical problem that should not be underestimated in
critically ill patients, where the success rate of enteral
feeding related to the prescribed dose or to nutritional tar-
get is most often low and unpredictable [23]. In the
present and future studies, selection of patients on PN
only, or patients on successful and stable enteral feeding,
also will considerably limit external validity. Techniques
and protocols that are generalizable to most critically ill
patients being fed enterally, parenterally, or by a combin-
ation of the two, must be developed.
In the present study involving neurolosurgical ICU pa-
tients the observed EE level ranged from 19 to 31 kcal/
kg/24 h (median 25) during the initial week of the ICU
stay. In a general ICU population the values are often
lower during the initial week of stay (range 14 to 34
kcal/kg/24 h; median 21) as shown in a recent study
[24]. It may be that the patient group in this study had a
certain level of hypermetabolism (not severe), but we
cannot confirm this as a factor that invalidates our re-
sults. Hypermetabolism is repeatedly reported in studies
of neurosurgical critically ill patients [25]. The small but
statistically significant difference in measured EE be-
tween pre-study and 50% PN measurements may be
interpreted as a sign of overfeeding before the study
period, at least in some cases. The possibility of an insu-
lin effect related to the higher caloric intake during the
normocaloric feeding period was also considered. How-
ever, no such effect was detected.
Conclusion
In this pilot, whole-body protein kinetics were investi-
gated in a selected group of critically ill patients in the
neurosurgical ICU. Hypocaloric feeding was found to be
associated with a more negative protein balance, but
with unaltered amino acid oxidation, compared to
normocaloric feeding. Overall the protein content of thefeeding given was low, 0.53 g protein/kg/24 h and 1.07 g
protein/kg/24 h, respectively, in the two feeding proto-
cols. The major finding of the study, which evaluated the
nutritional support effect on critically ill patients, is the
usefulness of the whole-body protein turnover tech-
nique, combined with a 48-hour protocol, when compar-
ing two alternative feeding protocols in the individual
patient.
Key messages
 Whole-body protein turnover measurement is a
useful technique to elucidate the protein content of
feeding in the critically ill.
 Full nutrition with a standard IV formula gives a
better protein balance compared to hypocaloric
feeding.
 A protein supply of 1.1 g/kg/day as part of full
feeding does not enhance amino acid oxidation,
which would have been indicative of futile protein
supply.
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